Mixed results from regulator

TGA rebuffs Guild on advertising schedule change, while pain relieving agent moves to S2 A manufacturer's request to allow the advertising of preparations containing astrodrimer sodium has been rejected by the Therapeutic Goods Administration's Advisory Committee on Medicines Scheduling (ACMS). Proposed amendments to the existing Appendix F and Appendix H entries for astodrimer that would

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Covid jab a ‘bioweapon,’ pharmacist allegedly says
Next A voice for pharmacists